JP
Revvity Sites Globally
Select your location.
*e-commerce not available for this region.
HTRF Human LAG3 / MHCII Binding Kit, 500 Assay Points
HTRF Human LAG3 / MHCII Binding Kit, 500 Assay Points
Generic HTRF biochemical binding LAG3/MHCII image
| Feature | Specification |
|---|---|
| Application | Protein-Protein Interaction |
| Sample Volume | 2 µL |
Product variants
Unit Size: 500 assay points
Part #:
64LAG3PEG
Unit Size: 10,000 assay points
Part #:
64LAG3PEH
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption, and disposal requirements under European REACH regulations (EC 1907/2006).
HTRF Human LAG3 / MHCII Binding Kit, 500 Assay Points
Generic HTRF biochemical binding LAG3/MHCII image
HTRF Human LAG3 / MHCII Binding Kit, 500 Assay Points
Product information
Overview
The lymphocyte activation gene-3 (LAG-3), selectively transcribed in human activated T and NK cells, encodes a ligand for major histocompatibility complex (MHC) class II molecules. When LAG3 is bound to MHC II, T cell response is suppressed. Checkpoint inhibitors blocking LAG3/MHC II complex formation are generating considerable interest in cancer immunotherapy.
Specifications
| Application |
Protein-Protein Interaction
|
|---|---|
| Brand |
HTRF
|
| Detection Modality |
HTRF
|
| Product Group |
Kit
|
| Sample Volume |
2 µL
|
| Shipping Conditions |
Shipped in Dry Ice
|
| Target Class |
Binding Assay
|
| Target Species |
Human
|
| Technology |
TR-FRET
|
| Therapeutic Area |
Oncology & Inflammation
|
| Unit Size |
500 assay points
|
Video gallery
HTRF Human LAG3 / MHCII Binding Kit, 500 Assay Points
HTRF Human LAG3 / MHCII Binding Kit, 500 Assay Points
Resources
Are you looking for resources, click on the resource type to explore further.
Guide
HTRF solutions, guide to major applications
This guide provides you an overview of HTRF applications in several therapeutic areas.
How can we help you?
We are here to answer your questions.
